Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. (Q48247954)

9 February 2018

title

Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. (English)

1 reference

9 February 2018

0 references

Masanari Itokawa

1

1 reference

9 February 2018

Makoto Arai

2

1 reference

9 February 2018

Shuhei Kato

3

1 reference

9 February 2018

Yoko Ogata

4

1 reference

9 February 2018

Aizo Furukawa

5

1 reference

9 February 2018

Seiichi Haga

6

1 reference

9 February 2018

Hiroshi Ujike

7

1 reference

9 February 2018

Ichiro Sora

8

1 reference

9 February 2018

Kazuhiko Ikeda

9

1 reference

9 February 2018

Takeo Yoshikawa

10

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 August 2003

1 reference

9 February 2018

number of pages

3

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

9 February 2018

volume

347

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

202-204

1 reference

9 February 2018

The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean population

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

No leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y in Japanese population or Japanese with alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

Nerve Growth Factor‐Induced Differentiation in Neuroblastoma Cells Expressing TrkA but Lacking p75NGFR

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

A leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y was not identified in the Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900718-3

7 January 2021

10.1016/S0304-3940(03)00718-3

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

12875921

1 reference

9 February 2018